Hepatitis B
Home | Guide | Videos | Journals | Support Group | Clinical Trials | Health Surveys | News |
Home | Guide | Videos | Journals | Support Group | Clinical Trials | Health Surveys | News |
Condition: Chronic Hepatitis B
Interventions: Biological: hepatitis B immune; Drug: Pegylated interferon alfa
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting
Condition: Chronic Hepatitis B
Interventions: Drug: ABI-H0731; Drug: SOC NUC; Drug: Placebo Oral Tablet
Sponsor: Assembly Biosciences
Recruiting
Condition: Chronic Hepatitis B
Interventions: Drug: ABI-H0731; Drug: SOC NUC (ETV); Drug: Placebo Oral Tablet
Sponsor: Assembly Biosciences
Recruiting
Condition: Chronic Hepatitis B
Interventions: Drug: GS-9688; Drug: Placebo; Drug: OAV Therapy
Sponsor: Gilead Sciences
Recruiting
Condition: Hepatitis B
Interventions: Drug: JNJ-56136379; Drug: Placebo; Drug: NA (ETV or TDF)
Sponsor: Janssen Sciences Ireland UC
Recruiting
Condition: Chronic Hepatitis B
Intervention: Drug: TAF
Sponsor: Gilead Sciences
Recruiting
Condition: Chronic Hepatitis B
Interventions: Drug: TAF; Drug: Placebo
Sponsor: Gilead Sciences
Recruiting
Conditions: Hepatitis; HIV; Liver Cancer
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); Washington D.C. Veterans Affairs Medical Center
Recruiting